ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue--15,00066,122
Cost of Revenue50,11863,60756,84356,553
Gross Profit-50,118-63,607-41,8439,569
Operating Expenses
Research Development----
Selling General and Administrative23,89625,96923,02224,676
Non Recurring----
Total Operating Expenses74,01489,57679,86581,229
Operating Income or Loss-74,014-89,576-64,865-15,107
Income from Continuing Operations
Total Other Income/Expenses Net3,7424,3403,15910,077
Earnings Before Interest and Taxes-74,014-89,576-64,865-15,107
Interest Expense-36-50-68-55
Income Before Tax-70,272-85,236-61,706-5,030
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-70,272-85,236-61,706-5,030
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-70,272-85,236-61,706-5,030
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-70,272-85,236-61,706-5,030